ALZpath's pTau217 antibody anchors 86 presentations at AAIC 2026 as blood-based biomarker research reaches 205 studies
Eighty-six presentations at the Alzheimer's Association International Conference 2026 center on one proprietary instrument: ALZpath's pTau217 antibody. The presentations span clinical and diagnostic value across the…
Filed via prnewswire.com